Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Bio Key International (BKYI) over the last 16 years, with Q3 2025 value amounting to $43488.0.

  • Bio Key International's Change in Accured Expenses fell 5153.68% to $43488.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$55038.0, marking a year-over-year increase of 4656.66%. This contributed to the annual value of -$42116.0 for FY2024, which is 11528.37% down from last year.
  • Per Bio Key International's latest filing, its Change in Accured Expenses stood at $43488.0 for Q3 2025, which was down 5153.68% from $128478.0 recorded in Q2 2025.
  • Over the past 5 years, Bio Key International's Change in Accured Expenses peaked at $436339.0 during Q3 2023, and registered a low of -$236321.0 during Q1 2025.
  • For the 5-year period, Bio Key International's Change in Accured Expenses averaged around $34590.2, with its median value being $27465.0 (2021).
  • Per our database at Business Quant, Bio Key International's Change in Accured Expenses skyrocketed by 5433930.13% in 2021 and then plummeted by 39651.84% in 2023.
  • Over the past 5 years, Bio Key International's Change in Accured Expenses (Quarter) stood at $129575.0 in 2021, then soared by 34.67% to $174496.0 in 2022, then tumbled by 129.55% to -$51570.0 in 2023, then soared by 118.07% to $9317.0 in 2024, then skyrocketed by 366.76% to $43488.0 in 2025.
  • Its Change in Accured Expenses was $43488.0 in Q3 2025, compared to $128478.0 in Q2 2025 and -$236321.0 in Q1 2025.